LETROZOLE DEXCEL

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

LETROZOLE

Mevcut itibaren:

DEXCEL LTD, ISRAEL

ATC kodu:

L02BG04

Farmasötik formu:

FILM COATED TABLETS

Kompozisyon:

LETROZOLE 2.5 MG

Uygulama yolu:

PER OS

Reçete türü:

Required

Tarafından üretildi:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Terapötik grubu:

LETROZOLE

Terapötik alanı:

LETROZOLE

Terapötik endikasyonlar:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Yetkilendirme tarihi:

2016-02-29